DATABASE
Home
Database
Who We Are
What We Offer
Register
Sign In
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Name
Category
Morphosys AG Earnings Call scheduled for 8:00 am ET today
News
MorphoSys AG Reports Results for Fiscal Year 2012
News
MorphoSys Announces Clinical Milestone in Ophthalmology Program
News
MorphoSys Completes Sale of AbD Serotec to Bio-Rad
News
MorphoSys Declines as Europe Concern Hurts Stocks
News
MorphoSys Initiates Phase 2 Study of Anti-CD19 Antibody MOR208 in B-cell Acute Lymphoblastic Leukemia
News
MorphoSys Receives First Patent on Novel Antibody Platform Ylanthia in the US
News
MorphoSys Sells Drug to Glaxo for $577 Million Plus Royalties
News
MorphoSys Sells Drug to Glaxo for $577 Million Plus Royalties
News
MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
News
MorphoSys Surges on Novartis Takeover Speculation: Munich Mover
News
MorphoSys to Host Q1 2013 Conference Call on May 3, 2013
News
MorphoSys to Start Share Buy-Back Program
News
Morrie Tobin
Contact
Morris Chang
Contact
Morris John
Contact
Morris Capital Advisors, Llc
Bank
Morris Goldfarb
Contact
Morris Homan
Contact
Morris Offit
Contact
Morris Steven Stanford
Contact
Morris Tolly
Contact
Morris Young
Contact
Morrison (Wm) Supermarkets PLC
Fund
Morrison 12-Week Revenue Rises for Second Month, Kantar Reports
News
Page 588 of 642
Page 588 of 642
Page 588 of 642